Name
TEE
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for TEE
Name
Alternate Names
Emcyt
Emcyt IV
Estracyt
Estramustine phosphate disodium
Leo 275
Leo275
Ro 21-8837
Ro 21-8837/001
Ro 218837
Ro 22-2296/000
Ro 222296/000
Ro-218837
Abbreviations
None
Category
Chemotherapy
Subcategory
Antimicrotubule agent
NSC Number
089199
089201
89199
Primary Site
Prostate cancer
Histology
None
Remarks
A nitrogen mustard antineoplastic agent. Chemotoxic hormone. An antineoplastic agent consisting of estradiol joined to nornitrogen mustard by a carbamate link, phosphorylated to make it water soluble; used for palliative treatment of metastatic or progressive carcinoma of the prostate. Single agent or combined with taxane for HRPC. FDA approved use on prostate cancer. Pharamcia.
Coding
This drug should be coded
Name
Alternate Names
Dom-Etoposide
Epipodophyllotoxin derivative
Epipodophyllotoxin ethylidene gluco-pyranoside
Eposine
Ethylidene-Lignan P
Etopophos
Podophyllotoxin derivative
Vepesid
VP 16-213
VP-16
VP-16213
Toposar
Abbreviations
EPEG
VP-16
VP-16-213
Category
Chemotherapy
Subcategory
Epipodophyllotoxin, topoisomerase II inhibitor
Plant alkaloid
NSC Number
141540
Primary Site
Histology
None
Remarks
Coding
This drug should be coded
Name
Alternate Names
BMS-181339-01
BMY-45622
Taxol
Abbreviations
None
Category
Chemotherapy
Subcategory
Mitotic inhibitor
plant alkaloid
Taxane
NSC Number
125973
673089
Primary Site
Histology
None
Remarks
Phase I (gastric) FDA approved uses on breast, ovarian, non-small cell lung cancers, and Kaposi's sarcoma. Bristol-Myers Squibb.
Coding
This drug should be coded